Symtuza

Showing 3 posts of 3 posts found.

janssen_latest_logo_on_sign_closer

Janssen’s Symtuza around 90% effective in achieving undetectable HIV-1 viral loads, when used immediately following diagnosis

April 12, 2019
Medical Communications HIV, Janssen, Symtuza, pharma

Janssen has lifted the curtain on data from the first Phase 3 trial investigating the efficacy of Symtuza (darunavir 800mg, …

nhs_sign

NHS England to fund availability of Janssen’s single tablet HIV combo Symtuza

October 1, 2018
Sales and Marketing HIV, Janssen, NHS, Symtuza, pharma

Great news for HIV patients in the UK as Janssen reveals that NHS England will provide critical funding for its …

janssen_latest_logo_on_sign

Janssen’s Symtuza scores approval with the FDA in HIV-1

July 18, 2018
Sales and Marketing HIV, Janssen, Symtuza, pharma

Janssen has announced that Symtuza (D/C/F/TAF) has received approval from the FDA in the treatment of human immunodeficiency virus type …

The Gateway to Local Adoption Series

Latest content